A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders

The immunomodulatory imide drug (IMiD) class, which includes the founding drug member thalidomide and later generation drugs, lenalidomide and pomalidomide, has dramatically improved the clinical treatment of specific cancers, such as multiple myeloma, and it combines potent anticancer and anti-infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopp, Katherine O., Greer, Margaret E., Glotfelty, Elliot J., Hsueh, Shih-Chang, Tweedie, David, Kim, Dong Seok, Reale, Marcella, Vargesson, Neil, Greig, Nigel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216254/
https://www.ncbi.nlm.nih.gov/pubmed/37238617
http://dx.doi.org/10.3390/biom13050747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216254/
https://www.ncbi.nlm.nih.gov/pubmed/37238617
http://dx.doi.org/10.3390/biom13050747

Ejemplares similares